Heart Rhythm Center, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital.
Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Curr Opin Cardiol. 2019 Jan;34(1):16-22. doi: 10.1097/HCO.0000000000000575.
Percutaneous catheter ablation is an effective treatment for atrial fibrillation. However, catheter ablation for the treatment of persistent atrial fibrillation or long-standing persistent atrial fibrillation is associated with unsatisfying success rates. This review aims to summarize the recent literature on the progress of catheter ablation among patients with persistent atrial fibrillation RECENT FINDINGS: In this review, we outline the potential future therapeutic techniques of catheter ablation of persistent atrial fibrillation. We highlight the innovative techniques (rotor mapping, substrate mapping, delayed enhancement MRI, and high-resolution mapping catheter) of current approaches and optimal procedural endpoint for persistent atrial fibrillation.
In summary, the optimal catheter ablation strategy for persistent atrial fibrillation remains unknown. Current data highlight the need for a better understanding of the substrate and mechanisms of arrhythmia maintenance in this population. Current mapping technologies offer additional tools (improved automatic algorithm for annotation, multiple electrode mapping, high-resolution mapping, and application of different processing techniques) for identifying the putative mechanism underlying atrial fibrillation. Further prospective studies are needed for the optimal procedural endpoint and the recent innovative techniques and their clinical benefits in ablation strategies.
经皮导管消融术是治疗心房颤动的有效方法。然而,对于持续性心房颤动或长期持续性心房颤动的治疗,导管消融术的成功率并不理想。本综述旨在总结目前关于持续性心房颤动患者导管消融术进展的文献。
在本综述中,我们概述了持续性心房颤动导管消融的潜在未来治疗技术。我们强调了当前方法的创新技术(转子标测、基质标测、延迟增强 MRI 和高分辨率标测导管)和持续性心房颤动的最佳程序终点。
总之,持续性心房颤动的最佳导管消融策略仍不清楚。目前的数据强调需要更好地了解该人群中心律失常维持的基质和机制。目前的映射技术为确定心房颤动潜在机制提供了额外的工具(改进的注释自动算法、多电极映射、高分辨率映射和不同处理技术的应用)。需要进一步的前瞻性研究来确定最佳的程序终点以及最近的创新技术及其在消融策略中的临床获益。